Increased allergic airway inflammation in the lungs of <i>NCR</i>^{<i>gfp/gfp</i>} mice.

<p><i>Ncr1</i>^<i>+/+</i> and <i>Ncr1</i>^{<i>gfp/gfp</i>} <i>C57Bl/6</i> mice were i.p. immunized with either OVA or adjuvant on days 0 and 14. Ten days after the second immunization, mice were challenged twice intranasally with OVA at days 24 and 27. 24 h following the second challenge, BALF was taken from each mouse and used in ELISA to detect levels of (A) CCL24 (n = 8 to 11), (B) CCL17 (n = 9 to 10) and CCL22 (n = 9–10). Results are the summary of 3 independent experiments and were normalized according to the OVA <i>NCR1</i>^<i>+/+</i> ± SEM group average that was considered as 1 in each experiment. **<i>p</i><0.01, ***<i>p<</i>0.001 (two-tailed Student <i>t-</i>test).